The Food and Drug Administration is expected to grant full approval to the Pfizer-BioNTech coronavirus vaccine early next week, sources told Axios on Friday.
Why it matters: It would be the first COVID-19 shot to receive full authorization from the federal government.
- A full approval could help boost vaccination efforts, as many Americans have been hesitant to get inoculated with shots that were only authorized for emergency use.
- Politico first reported the story.
https://news.yahoo.com/pfizers-covid-19-vaccine-full-220040748.html